ALX Oncology Ownership | Who Owns ALX Oncology?

Overview Forecast RevenueFinancials Chart

ALX Oncology Ownership Summary

ALX Oncology is owned by 86.27% institutional investors, 1.91% insiders, and 11.82% retail investors. Venbio partners is the largest institutional shareholder, holding 19.35% of ALXO shares. Fidelity Small Cap Growth is the top mutual fund, with 3.21% of its assets in ALX Oncology shares.

ALXO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	ALX Oncology	86.27%	1.91%	11.82%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Venbio partners	9.70M	19.35%	$58.49M
Fmr	7.81M	15.59%	$47.12M
Vivo capital	4.22M	8.42%	$25.45M
Redmile group	4.04M	8.05%	$24.34M
Blackrock	2.69M	5.36%	$16.21M
Bioimpact capital	2.18M	4.35%	$13.15M
Vanguard group	1.73M	3.45%	$10.42M
State street	705.55K	1.41%	$4.25M
Geode capital management	700.41K	1.40%	$4.22M
Morgan stanley	673.36K	1.34%	$4.06M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Venbio partners	9.70M	25.26%	$58.49M
Vivo capital	4.22M	2.35%	$25.45M
Bioimpact capital	2.18M	2.04%	$13.15M
Redmile group	4.04M	1.47%	$24.34M
Privium fund management b.v.	396.97K	0.58%	$2.27M
Nan fung group	41.95K	0.27%	$252.96K
Affinity asset advisors	100.00K	0.07%	$603.00K
Kennedy capital management	307.53K	0.04%	$1.85M
Virtus etf advisers	10.73K	0.03%	$64.68K
Sherbrooke park advisers	22.17K	0.02%	$133.70K

Top Buyers

Holder	Shares	% Assets	Change
Bioimpact capital	2.18M	2.04%	912.39K
Marshall wace, llp	635.68K	0.01%	514.13K
Blackrock	2.69M	0.00%	466.06K
Privium fund management b.v.	396.97K	0.58%	396.97K
Morgan stanley	673.36K	0.00%	330.22K

Top Sellers

Holder	Shares	% Assets	Change
Vestal point capital, lp	-	-	-3.60M
Cormorant asset management, lp	-	-	-3.14M
Orbimed advisors	-	-	-1.89M
Paradigm biocapital advisors lp	-	-	-1.58M
Point72 asset management	-	-	-304.10K

New Positions

Holder	Shares	% Assets	Change	Value
Privium fund management b.v.	396.97K	0.58%	396.97K	$2.27M
Kennedy capital management	307.53K	0.04%	307.53K	$1.85M
Jacobs levy equity management	232.02K	0.01%	232.02K	$1.40M
Affinity asset advisors	100.00K	0.07%	100.00K	$603.00K
Verition fund management	32.57K	0.00%	32.57K	$196.40K

Sold Out

Holder	Change
Creekmur asset management	-4.00
Farther finance advisors	-4.00
Nelson, van denburg & campbell wealth management group	-5.00
Gamma investing	-12.00
Signaturefd	-20.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	95	-18.80%	45,459,170	-6.37%	86	0.92%	58	-15.94%	22	-15.38%
Jun 30, 2024	117	4.46%	48,553,785	6.04%	96	1.16%	69	32.69%	26	-16.13%
Mar 31, 2024	112	14.29%	45,786,300	0.25%	91	0.81%	52	-21.21%	31	93.75%
Dec 31, 2023	98	20.99%	45,673,866	37.23%	106	1.62%	66	88.57%	16	-30.43%
Sep 30, 2023	81	1.25%	33,283,236	-2.95%	80	1.15%	35	-5.41%	23	27.78%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Small Cap Growth	1.69M	3.21%	-78.26K
HBM Healthcare Investments AG Ord	1.50M	2.85%	-
Fidelity Series Small Cap Opps	1.06M	2.01%	13.03K
Vanguard Total Stock Mkt Idx Inv	984.59K	1.87%	-
Fidelity Advisor Biotechnology I	924.23K	1.75%	-
iShares Russell 2000 ETF	867.20K	1.64%	-1.95K
Fidelity Select Biotechnology	835.50K	1.59%	-
Fidelity Small Cap Value Fund	678.40K	1.29%	-
Fidelity Small Cap Growth K6	621.50K	1.18%	-25.03K
Fidelity Stock Selector Small Cap	528.30K	1.00%	8.20K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 02, 2024	Hemrajani Rekha	-	Buy	$46.40K
Aug 14, 2024	Pinto Shelly	SVP, FINANCE AND CAO	Sell	$1.46K
Aug 14, 2024	Randolph Sophia	CHIEF MEDICAL OFFICER	Sell	$3.52K
Aug 14, 2024	Pons Jaume	PRESIDENT & CSO	Sell	$5.00K
Jul 11, 2024	Pons Jaume	PRESIDENT & CSO	Sell	$158.08K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	1	-
2024 Q3	-	8
2024 Q2	1	6
2024 Q1	1	1
2023 Q4	-	4

ALXO Ownership FAQ

Who Owns ALX Oncology?

ALX Oncology shareholders are primarily institutional investors at 86.27%, followed by 1.91% insiders and 11.82% retail investors. The average institutional ownership in ALX Oncology's industry, Biotech Stocks , is 47.04%, which ALX Oncology exceeds.

Who owns the most shares of ALX Oncology?

ALX Oncology’s largest shareholders are Venbio partners (9.7M shares, 19.35%), Fmr (7.81M shares, 15.59%), and Vivo capital (4.22M shares, 8.42%). Together, they hold 43.37% of ALX Oncology’s total shares outstanding.

Does Blackrock own ALX Oncology?

Yes, BlackRock owns 5.36% of ALX Oncology, totaling 2.69M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 16.21M$. In the last quarter, BlackRock increased its holdings by 466.06K shares, a 20.98% change.

Who is ALX Oncology’s biggest shareholder by percentage of total assets invested?

Venbio partners is ALX Oncology’s biggest shareholder by percentage of total assets invested, with 25.26% of its assets in 9.7M ALX Oncology shares, valued at 58.49M$.

Who is the top mutual fund holder of ALX Oncology shares?

Fidelity Small Cap Growth is the top mutual fund holder of ALX Oncology shares, with 3.21% of its total shares outstanding invested in 1.69M ALX Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools